Airswift Technology and Cloud Payments Partner to Enable Instant Access to Crypto with VISA and MasterCard
2.2.2023 01:04:00 EET | Business Wire | Press release
Airswift Technology Limited, a leading Web3.0 native payment company, and Cloud Payments, a digital payments and banking technology platform provider have joined forces to enable cryptocurrency spenders with instant access to crypto at the points-of-sale using VISA and MasterCard payment methods.
The collaboration will simplify crypto-based purchases by providing crypto on-ramping and NFT purchasing using VISA and MasterCard with optimized exchange rates. This offers crypto spenders increased convenience when shopping for retail goods and digital assets.
“Millions of Web2.0 consumers are ready to onboard to Web3.0, but are not familiar with existing Decentralized Finance (DeFi) on-ramps,” said Dr. Yan Zhang, co-founder and CEO of Airswift. “So we’ve worked together to integrate Cloud Payments' simple, credit-card based crypto purchasing tools into our easy-to-use crypto payment platform. This feature lets you seamlessly on-ramp to and spend crypto right at the checkout without ever leaving Airswift’s platform, thereby reducing friction for newcomers to the market.”
“Our patented technology platform enables Web2.0 consumers and merchants to easily transition into emerging Web3.0 payment and commerce methods as that segment of our industry continues to rapidly grow. Our partnership with Airswift will create a best-in-class crypto payment experience,” said Mike Love, co-founder and CEO of Cloud Payments.
The on-ramp service will be rolled out first in North America and Europe.
About Airswift
Airswift is a financial technology company pioneering crypto payment solutions for businesses and consumers around the globe. It provides a decentralized payment protocol, an on-chain trade financing platform and on/off ramp services that connect businesses with consumers. Airswift is widely recognized as a leader in blockchain technology, with extensive operational experience in global digital payments and enterprise Web 3.0 financial infrastructure. Headquartered in Vancouver Canada, Airswift was established in 2022 with backing from leading industry investors.
About Cloud Payments
Cloud Payments, a wholly owned subsidiary of mobile wallet unicorn Fintiv Inc, is a global leader in digital payment and embedded finance ecosystems. It deploys patented, industry-leading technology to optimize consumer and merchant payments simultaneously enabling clients to transition from legacy payment systems into the Digital Economy. Established in 2019, Cloud Payments is based in Austin, Texas serving a blue chip client base with safe and secure Web2.0 and Web3.0 solutions.
For more information, visit airswift.io or Cloud Payments.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230201006045/en/
Contact information
Annie Lin
PR@airswift.io
+1-604-337-8738
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release
Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob
Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release
VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom